32.50.Z - Production of medical devices, instruments, and products, including dental products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.99.Z - Retail trade
70.22.Z - Head office activities and management consultancy
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,1 | -0,4 | -0,1 | 85 |
EBITDA | -0,1 | -0,4 | -0,1 | 82,4 |
Short time liabilities | 0,1 | 0,1 | 0 | -87,9 |
Equity capital | 1,9 | 1,5 | 1,4 | -4,4 |
Operating profit (EBIT) | -0,1 | -0,4 | -0,1 | 82,1 |
Assets | 3,9 | 5,9 | 6,5 | 9,6 |
Net profit (loss) | -0,1 | -0,4 | -0,1 | 85 |
Cash | 0,9 | 0,5 | 0,1 | -73,3 |
Liabilities and provisions for liabilities | 2 | 4,5 | 5,1 | 14,2 |
Net income from sale | 0 | 0 | 0 | -42,9 |
Working assets | 1 | 1,1 | 0,3 | -76,5 |
Depreciation | 0 | 0 | 0 | -∞ |
% | % | % | p.p. | |
Profitability of capital | -2,8 | -29,1 | -4,6 | 24,5 |
Equity capital to total assets | 49,4 | 24,9 | 21,7 | -3,2 |
Gross profit margin | -17 580,6 | -61 628,6 | -16 140 | 45 488,6 |
EBITDA Margin | -17 759,3 | -55 145 | -16 944,6 | 38 200,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 110 088 | 48 404 | 10 289 | -38 115 |
Current financial liquidity indicator | 0.5348985195159912 | 0.24013826251029968 | 0.04931721091270447 | -0,2 |
Net dept to EBITDA | 16.51900863647461 | 1.2494680881500244 | 1.8969228267669678 | 0,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane